Announcement on Wholly-owned subsidiary's Obtaining Registration Certificate for Drug Substance of Cefditoren Pivoxil from the Republic of Korea

About this update from Zhejiang East Asia Pharmaceutical Co., Ltd. Class A

Announcement on Wholly-owned subsidiary's Obtaining Registration Certificate for Drug Substance of Cefditoren Pivoxil from the Republic of KoreaThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Zhejiang East Asia Pharmaceutical Co., Ltd. Class A